共 50 条
- [2] PROSPECTIVE TRIAL INCORPORATING PRE-/MID-TREATMENT [18F]-MISONIDAZOLE POSITRON EMISSION TOMOGRAPHY FOR HEAD-AND-NECK CANCER PATIENTS UNDERGOING CONCURRENT CHEMORADIOTHERAPY INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (01): : 101 - 108
- [3] Correlation of dynamic contrast enhanced magnetic resonance imaging (DCE MRI) with 18f-fluoromisonidazole positron emission and computed tomography (18F-FMISO PET/CT) in assessing tumor hypoxia in a series of head and neck cancer (HNC) patients with nodal metastases JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
- [4] Correlation of 18F-Fluoromisonidazole Positron Emission and Computed Tomography (18F-FMISO PET/CT) with Dynamic Contrast Enhanced Magnetic Resonance Imaging (DCE MRI) in Assessing Tumor Hypoxia in Head and Neck Cancer(HNC) Patients with Nodal Metastases INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : S176 - S176
- [6] Early Evaluation of Response to Chemoradiation in Head-and-Neck Squamous Cell Cancer (HNSCC) With F-18 Fluorothymidine Positron Emission Tomography (FLT PET) INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S522 - S522
- [7] 18F-fludeoxyglucose positron emission computed tomography (18F-FDG-PET/CT) versus 68Ga-DOTATATE-PET/CT in patients with head and neck cancer: Comparisons and implications for treatment HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2023, 45 (02): : 347 - 354